Storia in 1 fonti

Bernstein starts BioNTech at Market Perform, sees high registration risk

Bernstein initiated coverage of BioNTech (BNTX) with a Market Perform rating and $96 price target Investors should pass on BioNTech at this t...

Raccontata da